Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Proteomics International Laboratories has a Cash Ratio of 3.09. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.
ASX:PIQ's Cash Ratio is ranked better than 51.52% of 1386
companies
in the Biotechnology industry
Industry Median: 2.93
vs ASX:PIQ: 3.09
Proteomics International Laboratories (ASX:PIQ) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Proteomics International Laboratories Cash Ratio Related Terms
Proteomics International Laboratories Cash Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Proteomics International Laboratories Cash Ratio Chart
ASX:PIQ vs VRTX, REGN, ALNY: Cash Ratio Comparison
For the Biotechnology subindustry, Proteomics International Laboratories's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Proteomics International Laboratories Cash Ratio vs Biotechnology Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Proteomics International Laboratories (ASX:PIQ) has a Cash Ratio of 3.09 as of Dec. 2025. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Proteomics International Laboratories and its competitors. This is 32% below median its historical median of 4.52. Over the past decade, Proteomics International Laboratories' Cash Ratio has ranged from 0.83 to 10.01. According to the industry distribution chart, Proteomics International Laboratories ranks #672 out of 1386 companies in the Biotechnology industry, placing it in the top 48.5%.
Is Proteomics International Laboratories' Cash Ratio too high?
Proteomics International Laboratories' current Cash Ratio of 3.09 is 32% below median its 10-year median of 4.52. Over the past 10 years, this metric has ranged from a low of 0.83 to a high of 10.01. The Biotechnology industry median Cash Ratio is 2.93. Proteomics International Laboratories' value of 3.09 is 5.5% above this industry median. Based on the distribution chart, Proteomics International Laboratories ranks #672 out of 1386 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Proteomics International Laboratories has a GF Score™ of 31/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Proteomics International Laboratories' Cash Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Proteomics International Laboratories ranks #672 out of 1386 companies for Cash Ratio. This puts Proteomics International Laboratories in the upper half of its industry. The industry median Cash Ratio is 2.93. Proteomics International Laboratories' value of 3.09 is 5.5% above this benchmark. Historically, Proteomics International Laboratories' own Cash Ratio has ranged from 0.83 to 10.01 over the past decade. While the company's 10-year median is 4.52 vs. the industry median of 2.93, Proteomics International Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Biotechnology company?
The median Cash Ratio among Biotechnology companies is 2.93, based on 1,386 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Proteomics International Laboratories's current Cash Ratio of 3.09 is 5.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Proteomics International Laboratories and its competitors. For the Biotechnology industry, the median Cash Ratio is 2.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Proteomics International Laboratories's current Cash Ratio is 3.09, which is 32% below median its own 10-year median of 4.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Proteomics International Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Proteomics International Laboratories (ASX:PIQ) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.48, compared to a current price of A$0.20 — trading 59.4% below its estimated fair value. The current Cash Ratio is 3.09, which is 32% below median its 10-year median of 4.52 and 5.5% above the Biotechnology industry median of 2.93. Proteomics International Laboratories' overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Proteomics International Laboratories (ASX:PIQ), the current Cash Ratio is 3.09 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Proteomics International Laboratories (ASX:PIQ) Overvalued in 2026?
Based on GuruFocus' analysis, Proteomics International Laboratories stock appears to be undervalued.
The current stock price of A$0.20 is trading 59.4% below its estimated GF Value™ of A$0.48.
GuruFocus considers Proteomics International Laboratories to be Possible Value Trap.
Key valuation signals for ASX:PIQ:
Cash Ratio: 3.09 (32% below median its 10-year median of 4.52)
GF Value™: A$0.48 vs. price of A$0.20 (59.4% below fair value)
Industry Position: 5.5% above the Biotechnology median (#672 of 1386)
No single metric tells the full story. See the ASX:PIQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Proteomics International Laboratories Business Description
Proteomics International Laboratories Ltd is a biological research and drug discovery company. It is a pioneering medical technology company operating at the forefront of predictive diagnostics and precision medicine. The Company specialises in proteomics-the industrial-scale study of the structure and function of proteins. Its pipeline includes Promarker, Pipeline PromarkerD, PromarkerEndo, PromarkerEso, and OxiDx.
31GF Score
Get the complete analysis for ASX:PIQ
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:PIQ has been successfully added to your 
